Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

This study reveals efficient synthesis of ibuprofen:nicotinamide co-crystals via mechanochemistry, highlighting ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

is working to facilitate international harmonization in the interpretation and application of technical guidelines and requirements for the pharmaceutical industry. The growth promotion test The ...

As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in ... to energy suppliers and pharmaceutical companies.

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...

To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Angel Smith Although the revenue and EPS for Teva Pharmaceutical ...

Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell ...

Researchers have developed a new chemical tool that could help lower the cost of prescription medications. The tool, called AshPhos, is a ligand, or molecule, that makes it easier to create special ...

AbbVie (NYSE:ABBV) continues to navigate the challenges of Humira's loss of exclusivity while leveraging its diverse portfolio and robust pipeline to drive future growth. With a gross profit margin of ...